Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)
| 4.30 Delayed Data As of Oct 03 |  0.00 / 0.00%Today’s Change | 4.10 Today|||52-Week Range 39.36 | -74.77% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 18.3K | 89.1K | 104.2K | 125.7K | ||
| Operating Expenses | Gross Income | -18.3K | -89.1K | -104.2K | -125.7K | |
| General Expenses | 2.6M | 4.2M | 6.7M | 8.0M | ||
| Research And Development | 1.5M | 2.2M | 3.2M | 3.8M | ||
| Total Operating Expenses | 2.6M | 4.2M | 6.8M | 8.1M | ||
| Non-Operating Expenses | Operating Income | -2.6M | -4.2M | -6.8M | -8.1M | |
| Extraordinary Credit | 0.00 | -- | -- | 2.5M | ||
| Interest Expense On Debt | 0.00 | 8.6K | 0.00 | 0.00 | ||
| Other Expenses | -20.3K | 73.2K | -1.1M | -5.6K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -2.6M | -4.0M | -7.9M | -5.6M | |
| Net Income | -2.6M | -4.0M | -7.9M | -5.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 3.7M | 4.6M | 5.6M | 6.5M | |
| Shares To Calculate EPS Diluted | 3.7M | 4.6M | 5.6M | 6.5M | ||
| Earnings Per Share | EPS | -$0.71 | -$0.88 | -$1.41 | -$0.86 | |
| EPS Diluted | -$0.71 | -$0.88 | -$1.41 | -$0.86 | ||
